Molecular Subtype
Acute Myeloid Leukemia with NPM1 Mutation
CI-CAN-00008667Explore in graph →
Loading cancer entity…
Molecular Subtype
CI-CAN-00008667Explore in graph →
Variants & evidence
6 evidence items mapped to this entity or its descendants, grouped by molecular profile, then therapy. 50 items per page.
| Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|
| FLT3 N841I1 | |||||||
| (oncogenic) | Oncogenic | C | Supports Oncogenicity | 1 | submitted | EID12508To study the mutational spectrum in older AML patients over, 22 cases of NPM1-mutated de novo AML in patients older than 75 were sequenced and 76 mutations (50 different variants) were found across 16… (full text at CIViC) PMID 33711909 · Pettersson et al., 2021 · Open in CIViC | civic |
| NPM1 EXON 11 MUTATION2 | |||||||
| Revumenib | Predictive | B | Supports Sensitivity Response | 4 | submitted | EID13286In the phase 2 portion of AUGMENT-101 (NCT04065399), an open-label, single-arm, multicentre study, patients with relapsed or refractory NPM1-mutated acute myeloid leukaemia received the oral menin inh… (full text at CIViC) PMID 40332046 · Arellano et al., 2025 · Open in CIViC | civic |
| Ziftomenib | Predictive | B | Supports Sensitivity Response | 4 | submitted | EID13285In the registration-enabling phase II portion of KOMET-001 (NCT04067336), an open-label, single-arm, multicentre trial, 92 adults with relapsed or refractory NPM1-mutated acute myeloid leukaemia (NPM1… (full text at CIViC) PMID 40997296 · Wang et al., 2025 · Open in CIViC | civic |
| NPM1 MUTATION3 | |||||||
| (diagnostic) | Diagnostic | B | Supports Positive | 4 | accepted | EID12494In this 2005 study, immunohistochemical staining was used to assess the subcellular localization of NPM in 1,835 paraffin-embedded tumor specimens, including 591 from primary AML patients (ages 15–60)… (full text at CIViC) PMID 15659725 · Falini et al., 2005 · Open in CIViC | civic |
| 〃 | Diagnostic | B | Supports Positive | 3 | accepted | EID108In this publication, the role of NPM1 mutations in defining a distinct subset of acute myeloid leukemia (AML) was investigated. Among 1,485 adult AML patients enrolled in the multicenter AML96 protoco… (full text at CIViC) PMID 16455956 · Thiede et al., 2006 · Open in CIViC | civic |
| 〃 | Diagnostic | B | Supports Positive | 3 | accepted | EID12495In this 2005 study, the authors investigated the prevalence and prognostic impact of NPM1 mutation status in 300 adult patients with AML (16-60 years of age) with normal cytogenetics. The diagnostic b… | |
Data updated 23 hours agoSource updated unknownsource: civic (CC0)
Evidence levels, directions and ratings are those assigned by CIViC curators. "Submitted" items have not completed curation review. This is not treatment guidance.
PMID 16051734 · Döhner et al., 2005 · Open in CIViC
| civic |